Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression - PubMed (original) (raw)
Comparative Study
. 1996 Aug 1;56(15):3436-40.
Affiliations
- PMID: 8758908
Comparative Study
Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression
N M Mazure et al. Cancer Res. 1996.
Abstract
Hypoxia can select for cells that have lost their apoptotic potential, thereby making them resistant to adverse conditions. However, long-term survival of transformed cells which have diminished apoptotic sensitivity when exposed to low oxygen conditions would require the activation of their angiogenic program to compensate for an insufficient oxygen supply. In this report, we show that the activity (of oncogenic Ha-ras, either constitutively or transiently, enhances the induction of the angiogenic mitogen, vascular endothelial growth factor (VEGF), by hypoxia. Analysis of the 5' flanking region of the VEGF promoter indicates that a HIF-1-like sequence is to promote a 15-fold increase in reporter gene activity in Ha-ras-transformed cells when exposed to hypoxia, whereas mutations in the same site totally inhibited VEGF induction. Under low oxygen conditions, VEGF induction is inhibited in cells expressing a mutant inhibitory allele of Ha-ras (RasN17), indicating a direct role for Ras in modulating VEGF activity. We propose that the angiogenic switch in Ras-transformed cells may be physiologically promoted by the tumor microenvironment through VEGF induction.
Similar articles
- Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
Laderoute KR, Alarcon RM, Brody MD, Calaoagan JM, Chen EY, Knapp AM, Yun Z, Denko NC, Giaccia AJ. Laderoute KR, et al. Clin Cancer Res. 2000 Jul;6(7):2941-50. Clin Cancer Res. 2000. PMID: 10914744
Cited by
- Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis.
Yılmaz Y, Güneş A, Topel H, Atabey N. Yılmaz Y, et al. J Gastrointest Cancer. 2017 Sep;48(3):225-237. doi: 10.1007/s12029-017-9958-1. J Gastrointest Cancer. 2017. PMID: 28819741 Review. No abstract available. - Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expression.
Choi H, Gillespie DL, Berg S, Rice C, Couldwell S, Gu J, Colman H, Jensen RL, Huang LE. Choi H, et al. PLoS One. 2015 Apr 20;10(4):e0125125. doi: 10.1371/journal.pone.0125125. eCollection 2015. PLoS One. 2015. PMID: 25893706 Free PMC article. - Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.
Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, Stokoe D, Milanini-Mongiat J, Pages G, O'Rourke DM, Bernhard E, Maity A. Pore N, et al. Mol Biol Cell. 2004 Nov;15(11):4841-53. doi: 10.1091/mbc.e04-05-0374. Epub 2004 Sep 1. Mol Biol Cell. 2004. PMID: 15342781 Free PMC article. - The hemostatic system and angiogenesis in malignancy.
Wojtukiewicz MZ, Sierko E, Klement P, Rak J. Wojtukiewicz MZ, et al. Neoplasia. 2001 Sep-Oct;3(5):371-84. doi: 10.1038/sj.neo.7900184. Neoplasia. 2001. PMID: 11687948 Free PMC article. Review. - Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.
Okada F, Rak JW, Croix BS, Lieubeau B, Kaya M, Roncari L, Shirasawa S, Sasazuki T, Kerbel RS. Okada F, et al. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3609-14. doi: 10.1073/pnas.95.7.3609. Proc Natl Acad Sci U S A. 1998. PMID: 9520413 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials